Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: To WiN study

Jessica M. Heijdra, Wala Al Arashi, Marjon H. Cnossen, Michael E. Cloesmeijer, Laura H. Bukkems, Frank W.G. Leebeek, Ron A.A. Mathôt, Christian M. Zwaan, F. W.G. Leebeek, C. M. Zwaan, I. Van Vliet, M. J.H.A. Kruip, Polinder S Polinder, M. Coppens, R. Y.J. Tamminga, K. Meijer, B. A.P. Laros-Van, P. Brons, S. E.M. Schols, F. J.M. Van Der MeerH. C.J. Eikenboom, R. E.G. Schutgens, K. Fischer, F. Heubel-Moenen, L. Nieuwenhuizen, P. Ypma, M. H.E. Driessens, Collins Pw Collins, R. Liesner, P. Chowdary, D. KeelingToon overzicht 11 andereToon minder